Synthesis and Evaluation of Antimicrobial Activity of New Imides and Schiff Bases Derived From Ethyl-4-Amino Benzoate AARAAMRIALB WUROOD S. AHMED1 ORIENTAL JOURNAL OF CHEMISTRY 34 (5), 2477-2486, 2018 | 21 | 2018 |
Synthesis, docking study, and structureactivity relationship of novel niflumic acid derivatives acting as anticancer agents by inhibiting VEGFR or EGFR tyrosine kinase activities. Y Yaseen, A Kubba, W Shihab, L Tahtamouni Pharmacia (0428-0296) 69 (3), 2022 | 16 | 2022 |
New tolfenamic acid derivatives with hydrazine-1-carbothioamide and 1, 3, 4-oxadiazole moieties targeting VEGFR: synthesis, in silico studies, and in vitro anticancer assessment AAR Mehihi, AAR Kubba, WA Shihab, LH Tahtamouni Medicinal Chemistry Research 32 (11), 2334-2348, 2023 | 8 | 2023 |
New Niflumic Acid Derivatives as EGFR Inhibitors: Design, Synthesis, In-Silico Studies, and Anti-proliferative Assessment YS Yaseen, AAR Mahmood, AH Abbas, WA Shihab, LH Tahtamouni Medicinal Chemistry 19 (5), 445-459, 2023 | 7 | 2023 |
Insilico and in vitro Approach for Design, Synthesis, and Anti-proliferative Activity of Novel Derivatives of 5-(4-Aminophenyl)-4-Substituted Phenyl-2, 4-Dihydro-3H-1, 2, 4 … AA Kubba, WA Shihab, NN Al-Shawi Research Journal of Pharmacy and Technology 13 (7), 3329-3339, 2020 | 5 | 2020 |
Design and synthesis of novel derivatives of 4-(6-(4-Substituted Phenyl)-7H-[1, 2, 4] triazolo [3, 4-b][1, 3, 4] thiadiazin-3-yl) phenol as a possible tubulin-antitumor inhibitor AAR Kubba, WA Shihab, NN Al-Shawi, MS Jabir Indonesian Journal of Pharmacy 31 (2), 92-107, 2020 | 3 | 2020 |
In vitro and in silico evaluation of 4'-hydroxy-[1, 1'-biphenyl]-4-carbohydrazide Schiff base and oxadiazole derivatives targeting EGFR allosteric site WA Shihab, AAR Mahmood, LH Tahtamouni, MF AlSakhen, SI Kanaan, ... Chemical Papers 78 (14), 7951-7971, 2024 | 1 | 2024 |
Synthesis, In Silico Prediction, and In Vitro Evaluation of Anti-tumor Activities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivatives as … WA Shihab, AAR Kubba, LH Tahtamouni, KM Saleh, MF AlSakhen, ... Current Medicinal Chemistry 31 (38), 6336-6356, 2024 | | 2024 |